Project
averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for ZEB1
Z-value: 3.19
Motif logo
Transcription factors associated with ZEB1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
ZEB1
|
ENSG00000148516.17 | zinc finger E-box binding homeobox 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| ZEB1 | hg19_v2_chr10_+_31610064_31610159 | -0.27 | 6.4e-05 | Click! |
Activity profile of ZEB1 motif
Sorted Z-values of ZEB1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr17_-_7165662 | 61.72 |
ENST00000571881.2
ENST00000360325.7 |
CLDN7
|
claudin 7 |
| chr19_+_38755042 | 59.01 |
ENST00000301244.7
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2 |
| chr19_+_38755203 | 58.82 |
ENST00000587090.1
ENST00000454580.3 |
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2 |
| chr8_+_144816303 | 56.29 |
ENST00000533004.1
|
FAM83H-AS1
|
FAM83H antisense RNA 1 (head to head) |
| chr17_-_39942940 | 54.86 |
ENST00000310706.5
ENST00000393931.3 ENST00000424457.1 ENST00000591690.1 |
JUP
|
junction plakoglobin |
| chr19_-_12886327 | 48.83 |
ENST00000397668.3
ENST00000587178.1 ENST00000264827.5 |
HOOK2
|
hook microtubule-tethering protein 2 |
| chr11_-_68518910 | 42.56 |
ENST00000544963.1
ENST00000443940.2 |
MTL5
|
metallothionein-like 5, testis-specific (tesmin) |
| chr14_-_61747949 | 41.34 |
ENST00000355702.2
|
TMEM30B
|
transmembrane protein 30B |
| chr16_-_4987065 | 39.19 |
ENST00000590782.2
ENST00000345988.2 |
PPL
|
periplakin |
| chr19_+_35739782 | 36.62 |
ENST00000347609.4
|
LSR
|
lipolysis stimulated lipoprotein receptor |
| chr19_+_35739597 | 34.66 |
ENST00000361790.3
|
LSR
|
lipolysis stimulated lipoprotein receptor |
| chr15_+_41136586 | 34.02 |
ENST00000431806.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr19_+_35739631 | 31.57 |
ENST00000602003.1
ENST00000360798.3 ENST00000354900.3 |
LSR
|
lipolysis stimulated lipoprotein receptor |
| chr14_+_75745477 | 30.42 |
ENST00000303562.4
ENST00000554617.1 ENST00000554212.1 ENST00000535987.1 ENST00000555242.1 |
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
| chr19_-_3028354 | 30.02 |
ENST00000586422.1
|
TLE2
|
transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila) |
| chr19_+_35739897 | 29.91 |
ENST00000605618.1
ENST00000427250.1 ENST00000601623.1 |
LSR
|
lipolysis stimulated lipoprotein receptor |
| chr6_+_7541808 | 28.92 |
ENST00000379802.3
|
DSP
|
desmoplakin |
| chr17_+_20059302 | 28.86 |
ENST00000395530.2
|
SPECC1
|
sperm antigen with calponin homology and coiled-coil domains 1 |
| chr19_+_35739280 | 28.15 |
ENST00000602122.1
|
LSR
|
lipolysis stimulated lipoprotein receptor |
| chr6_+_7541845 | 28.15 |
ENST00000418664.2
|
DSP
|
desmoplakin |
| chr14_-_61748550 | 27.39 |
ENST00000555868.1
|
TMEM30B
|
transmembrane protein 30B |
| chr17_-_39684550 | 26.64 |
ENST00000455635.1
ENST00000361566.3 |
KRT19
|
keratin 19 |
| chr17_-_31204124 | 24.17 |
ENST00000579584.1
ENST00000318217.5 ENST00000583621.1 |
MYO1D
|
myosin ID |
| chr16_+_226658 | 24.02 |
ENST00000320868.5
ENST00000397797.1 |
HBA1
|
hemoglobin, alpha 1 |
| chr15_+_41136216 | 23.33 |
ENST00000562057.1
ENST00000344051.4 |
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
| chr19_-_14016877 | 22.93 |
ENST00000454313.1
ENST00000591586.1 ENST00000346736.2 |
C19orf57
|
chromosome 19 open reading frame 57 |
| chr7_-_16844611 | 22.83 |
ENST00000401412.1
ENST00000419304.2 |
AGR2
|
anterior gradient 2 |
| chr16_+_68771128 | 22.54 |
ENST00000261769.5
ENST00000422392.2 |
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial) |
| chr6_-_136871957 | 22.07 |
ENST00000354570.3
|
MAP7
|
microtubule-associated protein 7 |
| chr16_+_222846 | 21.58 |
ENST00000251595.6
ENST00000397806.1 |
HBA2
|
hemoglobin, alpha 2 |
| chr1_-_201368653 | 20.21 |
ENST00000367313.3
|
LAD1
|
ladinin 1 |
| chr1_-_201368707 | 20.04 |
ENST00000391967.2
|
LAD1
|
ladinin 1 |
| chr7_+_150497491 | 19.89 |
ENST00000484928.1
|
TMEM176A
|
transmembrane protein 176A |
| chr1_+_3370990 | 19.68 |
ENST00000378378.4
|
ARHGEF16
|
Rho guanine nucleotide exchange factor (GEF) 16 |
| chr8_-_90769422 | 19.53 |
ENST00000524190.1
ENST00000523859.1 |
RP11-37B2.1
|
RP11-37B2.1 |
| chr7_+_150497569 | 19.21 |
ENST00000004103.3
|
TMEM176A
|
transmembrane protein 176A |
| chr8_+_95653427 | 19.02 |
ENST00000454170.2
|
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr14_+_75746340 | 18.73 |
ENST00000555686.1
ENST00000555672.1 |
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
| chr19_-_6767516 | 18.72 |
ENST00000245908.6
|
SH2D3A
|
SH2 domain containing 3A |
| chr20_+_44098346 | 18.44 |
ENST00000372676.3
|
WFDC2
|
WAP four-disulfide core domain 2 |
| chr1_-_153588765 | 18.18 |
ENST00000368701.1
ENST00000344616.2 |
S100A14
|
S100 calcium binding protein A14 |
| chr17_+_1665345 | 18.18 |
ENST00000576406.1
ENST00000571149.1 |
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
| chr17_+_73521763 | 18.08 |
ENST00000167462.5
ENST00000375227.4 ENST00000392550.3 ENST00000578363.1 ENST00000579392.1 |
LLGL2
|
lethal giant larvae homolog 2 (Drosophila) |
| chr1_-_209979375 | 18.03 |
ENST00000367021.3
|
IRF6
|
interferon regulatory factor 6 |
| chr1_-_153588334 | 18.01 |
ENST00000476873.1
|
S100A14
|
S100 calcium binding protein A14 |
| chr16_+_55542910 | 17.60 |
ENST00000262134.5
|
LPCAT2
|
lysophosphatidylcholine acyltransferase 2 |
| chr2_-_99224915 | 17.50 |
ENST00000328709.3
ENST00000409997.1 |
COA5
|
cytochrome c oxidase assembly factor 5 |
| chr3_-_128712955 | 17.46 |
ENST00000265068.5
|
KIAA1257
|
KIAA1257 |
| chr8_+_95653373 | 17.42 |
ENST00000358397.5
|
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr8_+_95653302 | 17.39 |
ENST00000423620.2
ENST00000433389.2 |
ESRP1
|
epithelial splicing regulatory protein 1 |
| chr19_-_6767431 | 17.32 |
ENST00000437152.3
ENST00000597687.1 |
SH2D3A
|
SH2 domain containing 3A |
| chr3_-_187388173 | 17.27 |
ENST00000287641.3
|
SST
|
somatostatin |
| chr1_-_59043166 | 17.20 |
ENST00000371225.2
|
TACSTD2
|
tumor-associated calcium signal transducer 2 |
| chr14_-_65409438 | 17.18 |
ENST00000557049.1
|
GPX2
|
glutathione peroxidase 2 (gastrointestinal) |
| chr19_+_58095501 | 17.18 |
ENST00000536878.2
ENST00000597850.1 ENST00000597219.1 ENST00000598689.1 ENST00000599456.1 ENST00000307468.4 |
ZIK1
|
zinc finger protein interacting with K protein 1 |
| chr22_-_50312052 | 16.96 |
ENST00000330817.6
|
ALG12
|
ALG12, alpha-1,6-mannosyltransferase |
| chr22_+_40390930 | 16.80 |
ENST00000333407.6
|
FAM83F
|
family with sequence similarity 83, member F |
| chr13_+_42031679 | 16.72 |
ENST00000379359.3
|
RGCC
|
regulator of cell cycle |
| chr19_+_39897453 | 16.59 |
ENST00000597629.1
ENST00000248673.3 ENST00000594045.1 ENST00000594442.1 |
ZFP36
|
ZFP36 ring finger protein |
| chr7_-_22396533 | 16.43 |
ENST00000344041.6
|
RAPGEF5
|
Rap guanine nucleotide exchange factor (GEF) 5 |
| chr19_+_55587266 | 16.34 |
ENST00000201647.6
ENST00000540810.1 |
EPS8L1
|
EPS8-like 1 |
| chr19_+_41509851 | 16.33 |
ENST00000593831.1
ENST00000330446.5 |
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6 |
| chrX_-_107018969 | 16.23 |
ENST00000372383.4
|
TSC22D3
|
TSC22 domain family, member 3 |
| chr14_+_75746781 | 16.18 |
ENST00000555347.1
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
| chr8_+_102504651 | 16.18 |
ENST00000251808.3
ENST00000521085.1 |
GRHL2
|
grainyhead-like 2 (Drosophila) |
| chr11_+_394196 | 16.14 |
ENST00000331563.2
ENST00000531857.1 |
PKP3
|
plakophilin 3 |
| chr10_-_50747064 | 16.10 |
ENST00000355832.5
ENST00000603152.1 ENST00000447839.2 |
ERCC6
PGBD3
ERCC6-PGBD3
|
excision repair cross-complementing rodent repair deficiency, complementation group 6 piggyBac transposable element derived 3 ERCC6-PGBD3 readthrough |
| chr1_-_153363452 | 15.81 |
ENST00000368732.1
ENST00000368733.3 |
S100A8
|
S100 calcium binding protein A8 |
| chr15_+_74833518 | 15.74 |
ENST00000346246.5
|
ARID3B
|
AT rich interactive domain 3B (BRIGHT-like) |
| chr1_-_160990886 | 15.68 |
ENST00000537746.1
|
F11R
|
F11 receptor |
| chr6_+_41604747 | 15.67 |
ENST00000419164.1
ENST00000373051.2 |
MDFI
|
MyoD family inhibitor |
| chr2_-_89340242 | 15.41 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
| chr11_+_82612740 | 15.39 |
ENST00000524921.1
ENST00000528759.1 ENST00000525361.1 ENST00000430323.2 ENST00000533655.1 ENST00000532764.1 ENST00000532589.1 ENST00000525388.1 |
C11orf82
|
chromosome 11 open reading frame 82 |
| chr20_+_44098385 | 15.34 |
ENST00000217425.5
ENST00000339946.3 |
WFDC2
|
WAP four-disulfide core domain 2 |
| chr16_+_30710462 | 15.26 |
ENST00000262518.4
ENST00000395059.2 ENST00000344771.4 |
SRCAP
|
Snf2-related CREBBP activator protein |
| chr6_-_36355513 | 15.22 |
ENST00000340181.4
ENST00000373737.4 |
ETV7
|
ets variant 7 |
| chr9_+_130911770 | 15.18 |
ENST00000372998.1
|
LCN2
|
lipocalin 2 |
| chr2_+_90248739 | 15.15 |
ENST00000468879.1
|
IGKV1D-43
|
immunoglobulin kappa variable 1D-43 |
| chr11_-_417388 | 15.13 |
ENST00000332725.3
|
SIGIRR
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
| chr4_-_57522470 | 15.07 |
ENST00000503639.3
|
HOPX
|
HOP homeobox |
| chr10_-_105452917 | 15.06 |
ENST00000427662.2
|
SH3PXD2A
|
SH3 and PX domains 2A |
| chr2_+_90198535 | 15.05 |
ENST00000390276.2
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
| chr3_+_153839149 | 15.04 |
ENST00000465093.1
ENST00000465817.1 |
ARHGEF26
|
Rho guanine nucleotide exchange factor (GEF) 26 |
| chr1_+_62208091 | 14.93 |
ENST00000316485.6
ENST00000371158.2 |
INADL
|
InaD-like (Drosophila) |
| chr6_+_151042224 | 14.91 |
ENST00000358517.2
|
PLEKHG1
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 1 |
| chr19_+_35606692 | 14.74 |
ENST00000406242.3
ENST00000454903.2 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
| chr11_-_417308 | 14.51 |
ENST00000397632.3
ENST00000382520.2 |
SIGIRR
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
| chr14_-_106330458 | 14.49 |
ENST00000461719.1
|
IGHJ4
|
immunoglobulin heavy joining 4 |
| chr1_+_26503894 | 14.30 |
ENST00000361530.6
ENST00000374253.5 |
CNKSR1
|
connector enhancer of kinase suppressor of Ras 1 |
| chr14_-_65409502 | 14.17 |
ENST00000389614.5
|
GPX2
|
glutathione peroxidase 2 (gastrointestinal) |
| chr20_+_49348081 | 14.14 |
ENST00000371610.2
|
PARD6B
|
par-6 family cell polarity regulator beta |
| chrX_-_40506766 | 13.94 |
ENST00000378421.1
ENST00000440784.2 ENST00000327877.5 ENST00000378426.1 ENST00000378418.2 |
CXorf38
|
chromosome X open reading frame 38 |
| chr19_+_35607166 | 13.80 |
ENST00000604255.1
ENST00000346446.5 ENST00000344013.6 ENST00000603449.1 ENST00000406988.1 ENST00000605550.1 ENST00000604804.1 ENST00000605552.1 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
| chr4_-_165898768 | 13.69 |
ENST00000329314.5
|
TRIM61
|
tripartite motif containing 61 |
| chr7_-_73038822 | 13.60 |
ENST00000414749.2
ENST00000429400.2 ENST00000434326.1 |
MLXIPL
|
MLX interacting protein-like |
| chr9_+_130911723 | 13.56 |
ENST00000277480.2
ENST00000373013.2 ENST00000540948.1 |
LCN2
|
lipocalin 2 |
| chr8_-_120651020 | 13.55 |
ENST00000522826.1
ENST00000520066.1 ENST00000259486.6 ENST00000075322.6 |
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
| chr2_+_47596287 | 13.54 |
ENST00000263735.4
|
EPCAM
|
epithelial cell adhesion molecule |
| chr12_-_6484715 | 13.50 |
ENST00000228916.2
|
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
| chr1_+_29213678 | 13.47 |
ENST00000347529.3
|
EPB41
|
erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) |
| chr7_-_150497406 | 13.47 |
ENST00000492607.1
ENST00000326442.5 ENST00000450753.2 |
TMEM176B
|
transmembrane protein 176B |
| chr10_-_62493223 | 13.17 |
ENST00000373827.2
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G) |
| chr16_-_68269971 | 12.99 |
ENST00000565858.1
|
ESRP2
|
epithelial splicing regulatory protein 2 |
| chr12_-_91576561 | 12.96 |
ENST00000547568.2
ENST00000552962.1 |
DCN
|
decorin |
| chr1_+_29213584 | 12.92 |
ENST00000343067.4
ENST00000356093.2 ENST00000398863.2 ENST00000373800.3 ENST00000349460.4 |
EPB41
|
erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) |
| chr2_-_24583314 | 12.90 |
ENST00000443927.1
ENST00000406921.3 ENST00000412011.1 |
ITSN2
|
intersectin 2 |
| chr16_+_89753070 | 12.71 |
ENST00000353379.7
ENST00000505473.1 ENST00000564192.1 |
CDK10
|
cyclin-dependent kinase 10 |
| chr11_+_121322832 | 12.52 |
ENST00000260197.7
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing |
| chr2_-_89399845 | 12.51 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
| chr7_-_73038867 | 12.46 |
ENST00000313375.3
ENST00000354613.1 ENST00000395189.1 ENST00000453275.1 |
MLXIPL
|
MLX interacting protein-like |
| chr3_-_49459865 | 12.44 |
ENST00000427987.1
|
AMT
|
aminomethyltransferase |
| chr7_+_73242069 | 12.43 |
ENST00000435050.1
|
CLDN4
|
claudin 4 |
| chr7_-_73184588 | 12.42 |
ENST00000395145.2
|
CLDN3
|
claudin 3 |
| chr14_+_105781102 | 12.38 |
ENST00000547217.1
|
PACS2
|
phosphofurin acidic cluster sorting protein 2 |
| chr6_-_36355486 | 12.31 |
ENST00000538992.1
|
ETV7
|
ets variant 7 |
| chr12_-_91576429 | 12.30 |
ENST00000552145.1
ENST00000546745.1 |
DCN
|
decorin |
| chr1_-_21948906 | 12.25 |
ENST00000374761.2
ENST00000599760.1 |
RAP1GAP
|
RAP1 GTPase activating protein |
| chr7_-_149470297 | 12.10 |
ENST00000484747.1
|
ZNF467
|
zinc finger protein 467 |
| chr4_-_186125077 | 12.07 |
ENST00000458385.2
ENST00000514798.1 ENST00000296775.6 |
KIAA1430
|
KIAA1430 |
| chr2_-_86333244 | 12.06 |
ENST00000263857.6
ENST00000409681.1 |
POLR1A
|
polymerase (RNA) I polypeptide A, 194kDa |
| chr5_+_156693159 | 12.01 |
ENST00000347377.6
|
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
| chr5_+_156693091 | 11.88 |
ENST00000318218.6
ENST00000442283.2 ENST00000522463.1 ENST00000521420.1 |
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
| chr18_+_61143994 | 11.84 |
ENST00000382771.4
|
SERPINB5
|
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
| chr17_+_1665253 | 11.72 |
ENST00000254722.4
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
| chr14_-_106209368 | 11.71 |
ENST00000390548.2
ENST00000390549.2 ENST00000390542.2 |
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
| chr16_-_2908155 | 11.68 |
ENST00000571228.1
ENST00000161006.3 |
PRSS22
|
protease, serine, 22 |
| chr22_-_31741757 | 11.64 |
ENST00000215919.3
|
PATZ1
|
POZ (BTB) and AT hook containing zinc finger 1 |
| chr16_-_28936493 | 11.64 |
ENST00000544477.1
ENST00000357573.6 |
RABEP2
|
rabaptin, RAB GTPase binding effector protein 2 |
| chr17_-_39743139 | 11.56 |
ENST00000167586.6
|
KRT14
|
keratin 14 |
| chr22_+_23229960 | 11.53 |
ENST00000526893.1
ENST00000532223.2 ENST00000531372.1 |
IGLL5
|
immunoglobulin lambda-like polypeptide 5 |
| chr5_-_79551838 | 11.42 |
ENST00000509193.1
ENST00000512972.2 |
SERINC5
|
serine incorporator 5 |
| chr22_+_41777927 | 11.41 |
ENST00000266304.4
|
TEF
|
thyrotrophic embryonic factor |
| chr11_-_111781454 | 11.40 |
ENST00000533280.1
|
CRYAB
|
crystallin, alpha B |
| chr4_+_40058411 | 11.36 |
ENST00000261435.6
ENST00000515550.1 |
N4BP2
|
NEDD4 binding protein 2 |
| chr2_-_71454185 | 11.35 |
ENST00000244221.8
|
PAIP2B
|
poly(A) binding protein interacting protein 2B |
| chr17_-_74023291 | 11.27 |
ENST00000586740.1
|
EVPL
|
envoplakin |
| chr1_+_60280458 | 11.26 |
ENST00000455990.1
ENST00000371208.3 |
HOOK1
|
hook microtubule-tethering protein 1 |
| chr5_-_149792295 | 11.22 |
ENST00000518797.1
ENST00000524315.1 ENST00000009530.7 ENST00000377795.3 |
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain |
| chr2_+_90139056 | 11.15 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
| chr4_+_166300084 | 11.15 |
ENST00000402744.4
|
CPE
|
carboxypeptidase E |
| chr20_+_36149602 | 11.10 |
ENST00000062104.2
ENST00000346199.2 |
NNAT
|
neuronatin |
| chr5_-_42811986 | 11.06 |
ENST00000511224.1
ENST00000507920.1 ENST00000510965.1 |
SEPP1
|
selenoprotein P, plasma, 1 |
| chr5_-_131132614 | 11.04 |
ENST00000307968.7
ENST00000307954.8 |
FNIP1
|
folliculin interacting protein 1 |
| chr5_-_138725560 | 11.04 |
ENST00000412103.2
ENST00000457570.2 |
MZB1
|
marginal zone B and B1 cell-specific protein |
| chr16_-_46865047 | 11.02 |
ENST00000394806.2
|
C16orf87
|
chromosome 16 open reading frame 87 |
| chr19_+_35606777 | 11.01 |
ENST00000604404.1
ENST00000435734.2 ENST00000603181.1 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
| chr7_+_102715315 | 11.01 |
ENST00000428183.2
ENST00000323716.3 ENST00000441711.2 ENST00000454559.1 ENST00000425331.1 ENST00000541300.1 |
ARMC10
|
armadillo repeat containing 10 |
| chr4_+_85504075 | 10.99 |
ENST00000295887.5
|
CDS1
|
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1 |
| chr15_-_102029873 | 10.99 |
ENST00000348070.1
ENST00000358417.3 ENST00000344273.2 |
PCSK6
|
proprotein convertase subtilisin/kexin type 6 |
| chr14_+_102027688 | 10.98 |
ENST00000510508.4
ENST00000359323.3 |
DIO3
|
deiodinase, iodothyronine, type III |
| chr19_-_51512804 | 10.98 |
ENST00000594211.1
ENST00000376832.4 |
KLK9
|
kallikrein-related peptidase 9 |
| chr7_-_8301682 | 10.95 |
ENST00000396675.3
ENST00000430867.1 |
ICA1
|
islet cell autoantigen 1, 69kDa |
| chr15_+_90777424 | 10.89 |
ENST00000561433.1
ENST00000559204.1 ENST00000558291.1 |
GDPGP1
|
GDP-D-glucose phosphorylase 1 |
| chr2_-_89292422 | 10.88 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
| chr17_-_38657849 | 10.87 |
ENST00000254051.6
|
TNS4
|
tensin 4 |
| chr3_-_196065248 | 10.85 |
ENST00000446879.1
ENST00000273695.3 |
TM4SF19
|
transmembrane 4 L six family member 19 |
| chr2_+_89901292 | 10.76 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
| chr17_+_72428218 | 10.74 |
ENST00000392628.2
|
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
| chr19_-_40324767 | 10.73 |
ENST00000601972.1
ENST00000430012.2 ENST00000323039.5 ENST00000348817.3 |
DYRK1B
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B |
| chr5_-_130970723 | 10.72 |
ENST00000308008.6
ENST00000296859.6 ENST00000507093.1 ENST00000510071.1 ENST00000509018.1 ENST00000307984.5 |
RAPGEF6
|
Rap guanine nucleotide exchange factor (GEF) 6 |
| chr5_-_138725594 | 10.68 |
ENST00000302125.8
|
MZB1
|
marginal zone B and B1 cell-specific protein |
| chr11_+_118401706 | 10.62 |
ENST00000411589.2
ENST00000442938.2 ENST00000359862.4 |
TMEM25
|
transmembrane protein 25 |
| chr17_-_15244894 | 10.61 |
ENST00000338696.2
ENST00000543896.1 ENST00000539245.1 ENST00000539316.1 ENST00000395930.1 |
TEKT3
|
tektin 3 |
| chr1_-_223537475 | 10.60 |
ENST00000344029.6
ENST00000494793.2 ENST00000366878.4 ENST00000366877.3 |
SUSD4
|
sushi domain containing 4 |
| chr14_-_24036943 | 10.59 |
ENST00000556843.1
ENST00000397120.3 ENST00000557189.1 |
AP1G2
|
adaptor-related protein complex 1, gamma 2 subunit |
| chr1_+_153330322 | 10.47 |
ENST00000368738.3
|
S100A9
|
S100 calcium binding protein A9 |
| chr7_-_150497621 | 10.44 |
ENST00000434545.1
|
TMEM176B
|
transmembrane protein 176B |
| chr9_+_131843377 | 10.36 |
ENST00000372546.4
ENST00000406974.3 ENST00000540102.1 |
DOLPP1
|
dolichyldiphosphatase 1 |
| chr12_-_91576750 | 10.33 |
ENST00000228329.5
ENST00000303320.3 ENST00000052754.5 |
DCN
|
decorin |
| chr16_+_68678739 | 10.33 |
ENST00000264012.4
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
| chr1_+_156030937 | 10.29 |
ENST00000361084.5
|
RAB25
|
RAB25, member RAS oncogene family |
| chr19_-_51504411 | 10.26 |
ENST00000593490.1
|
KLK8
|
kallikrein-related peptidase 8 |
| chr7_+_73242490 | 10.26 |
ENST00000431918.1
|
CLDN4
|
claudin 4 |
| chr19_+_42212501 | 10.18 |
ENST00000398599.4
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5 |
| chr14_-_106330072 | 10.12 |
ENST00000488476.1
|
IGHJ5
|
immunoglobulin heavy joining 5 |
| chr16_+_68679193 | 10.11 |
ENST00000581171.1
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
| chr21_+_41239243 | 10.09 |
ENST00000328619.5
|
PCP4
|
Purkinje cell protein 4 |
| chr3_-_49459878 | 10.05 |
ENST00000546031.1
ENST00000458307.2 ENST00000430521.1 |
AMT
|
aminomethyltransferase |
| chr4_-_120550146 | 10.01 |
ENST00000354960.3
|
PDE5A
|
phosphodiesterase 5A, cGMP-specific |
| chr3_-_122283100 | 10.01 |
ENST00000492382.1
ENST00000462315.1 |
PARP9
|
poly (ADP-ribose) polymerase family, member 9 |
| chr14_-_89878369 | 10.00 |
ENST00000553840.1
ENST00000556916.1 |
FOXN3
|
forkhead box N3 |
| chr7_+_142498725 | 9.97 |
ENST00000466254.1
|
TRBC2
|
T cell receptor beta constant 2 |
| chr1_+_145439306 | 9.96 |
ENST00000425134.1
|
TXNIP
|
thioredoxin interacting protein |
| chr14_+_76127529 | 9.95 |
ENST00000556977.1
ENST00000557636.1 ENST00000286650.5 ENST00000298832.9 |
TTLL5
|
tubulin tyrosine ligase-like family, member 5 |
| chr7_-_8301768 | 9.95 |
ENST00000265577.7
|
ICA1
|
islet cell autoantigen 1, 69kDa |
| chr2_+_17721920 | 9.93 |
ENST00000295156.4
|
VSNL1
|
visinin-like 1 |
| chr22_+_29469100 | 9.92 |
ENST00000327813.5
ENST00000407188.1 |
KREMEN1
|
kringle containing transmembrane protein 1 |
| chr22_-_44258360 | 9.91 |
ENST00000330884.4
ENST00000249130.5 |
SULT4A1
|
sulfotransferase family 4A, member 1 |
| chr3_-_46506358 | 9.90 |
ENST00000417439.1
ENST00000431944.1 |
LTF
|
lactotransferrin |
| chr19_-_18632861 | 9.87 |
ENST00000262809.4
|
ELL
|
elongation factor RNA polymerase II |
| chr22_+_45148432 | 9.83 |
ENST00000389774.2
ENST00000396119.2 ENST00000336963.4 ENST00000356099.6 ENST00000412433.1 |
ARHGAP8
|
Rho GTPase activating protein 8 |
| chr19_+_42212526 | 9.78 |
ENST00000598976.1
ENST00000435837.2 ENST00000221992.6 ENST00000405816.1 |
CEA
CEACAM5
|
Uncharacterized protein carcinoembryonic antigen-related cell adhesion molecule 5 |
| chr10_-_102790852 | 9.74 |
ENST00000470414.1
ENST00000370215.3 |
PDZD7
|
PDZ domain containing 7 |
| chr12_+_56732658 | 9.72 |
ENST00000228534.4
|
IL23A
|
interleukin 23, alpha subunit p19 |
| chr11_+_44587141 | 9.71 |
ENST00000227155.4
ENST00000342935.3 ENST00000532544.1 |
CD82
|
CD82 molecule |
| chr20_+_31823792 | 9.70 |
ENST00000375413.4
ENST00000354297.4 ENST00000375422.2 |
BPIFA1
|
BPI fold containing family A, member 1 |
| chr4_+_37455536 | 9.67 |
ENST00000381980.4
ENST00000508175.1 |
C4orf19
|
chromosome 4 open reading frame 19 |
| chr9_+_91933726 | 9.65 |
ENST00000534113.2
|
SECISBP2
|
SECIS binding protein 2 |
| chr13_-_45010939 | 9.58 |
ENST00000261489.2
|
TSC22D1
|
TSC22 domain family, member 1 |
| chrX_-_48433275 | 9.58 |
ENST00000376775.2
|
AC115618.1
|
Uncharacterized protein; cDNA FLJ26048 fis, clone PRS02384 |
Network of associatons between targets according to the STRING database.
First level regulatory network of ZEB1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 33.5 | 134.0 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 32.2 | 160.9 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 16.0 | 80.0 | GO:0002159 | desmosome assembly(GO:0002159) |
| 11.2 | 33.7 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 9.9 | 59.6 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 9.6 | 28.9 | GO:0032771 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 9.2 | 73.7 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 6.8 | 34.0 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 6.6 | 26.5 | GO:1900228 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 6.5 | 6.5 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 6.4 | 63.5 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 6.1 | 24.4 | GO:2000314 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 6.1 | 36.6 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 5.9 | 23.5 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 5.7 | 28.7 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 5.7 | 17.2 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 5.7 | 5.7 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
| 5.4 | 10.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 5.3 | 21.1 | GO:1900827 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 5.0 | 5.0 | GO:0071284 | cellular response to lead ion(GO:0071284) |
| 4.8 | 29.1 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 4.8 | 24.0 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
| 4.8 | 19.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 4.7 | 18.9 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 4.7 | 18.6 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 4.6 | 64.6 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 4.6 | 13.8 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 4.6 | 4.6 | GO:0009798 | axis specification(GO:0009798) |
| 4.6 | 4.6 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
| 4.5 | 63.0 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 4.5 | 22.5 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 4.4 | 17.7 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 4.4 | 4.4 | GO:0051885 | positive regulation of anagen(GO:0051885) |
| 4.4 | 17.6 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 4.3 | 12.8 | GO:0048627 | myoblast development(GO:0048627) |
| 4.2 | 12.7 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) |
| 4.2 | 29.4 | GO:0032119 | sequestering of zinc ion(GO:0032119) |
| 4.1 | 16.6 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 4.1 | 28.9 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 4.1 | 12.4 | GO:0055073 | cadmium ion homeostasis(GO:0055073) |
| 4.1 | 4.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 4.1 | 12.2 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 4.0 | 12.1 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 4.0 | 15.9 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
| 3.9 | 15.8 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 3.8 | 3.8 | GO:0061461 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
| 3.8 | 22.8 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 3.8 | 109.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 3.8 | 3.8 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
| 3.8 | 11.4 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
| 3.8 | 11.3 | GO:0071810 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 3.7 | 3.7 | GO:0009404 | toxin metabolic process(GO:0009404) |
| 3.6 | 3.6 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
| 3.6 | 14.4 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
| 3.6 | 14.2 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 3.5 | 17.6 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
| 3.5 | 28.1 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 3.5 | 14.0 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 3.5 | 3.5 | GO:0042593 | carbohydrate homeostasis(GO:0033500) glucose homeostasis(GO:0042593) |
| 3.4 | 10.3 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 3.4 | 23.9 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 3.4 | 13.6 | GO:2000569 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
| 3.4 | 3.4 | GO:0097384 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) cellular lipid biosynthetic process(GO:0097384) |
| 3.4 | 27.1 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 3.4 | 16.8 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 3.3 | 13.2 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 3.3 | 3.3 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 3.2 | 9.7 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 3.2 | 16.1 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 3.2 | 6.4 | GO:2000466 | negative regulation of glycogen (starch) synthase activity(GO:2000466) |
| 3.1 | 9.2 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) rRNA import into mitochondrion(GO:0035928) |
| 3.0 | 21.3 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
| 3.0 | 6.0 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
| 3.0 | 9.0 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) regulation of lactation(GO:1903487) |
| 3.0 | 35.6 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 3.0 | 8.9 | GO:0032025 | response to cobalt ion(GO:0032025) |
| 2.9 | 5.9 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
| 2.9 | 20.6 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 2.9 | 8.8 | GO:0071529 | cementum mineralization(GO:0071529) |
| 2.9 | 8.7 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
| 2.8 | 22.7 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 2.8 | 2.8 | GO:0019835 | cytolysis(GO:0019835) |
| 2.8 | 36.5 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 2.8 | 8.4 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 2.8 | 5.6 | GO:0021558 | trochlear nerve development(GO:0021558) |
| 2.8 | 11.0 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 2.8 | 8.3 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
| 2.8 | 19.3 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 2.8 | 8.3 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
| 2.7 | 8.2 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 2.6 | 7.9 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 2.6 | 2.6 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
| 2.6 | 5.2 | GO:0060364 | frontal suture morphogenesis(GO:0060364) |
| 2.6 | 5.2 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
| 2.6 | 7.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 2.5 | 14.9 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 2.5 | 7.4 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 2.5 | 7.4 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 2.5 | 9.9 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 2.5 | 19.7 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 2.4 | 43.4 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 2.4 | 7.1 | GO:0003383 | apical constriction(GO:0003383) mesoderm migration involved in gastrulation(GO:0007509) |
| 2.3 | 7.0 | GO:0090467 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
| 2.3 | 11.6 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 2.3 | 13.9 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 2.3 | 6.9 | GO:1902896 | terminal web assembly(GO:1902896) |
| 2.3 | 6.9 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 2.3 | 16.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 2.3 | 18.3 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 2.3 | 9.1 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 2.3 | 4.6 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
| 2.2 | 11.2 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 2.2 | 2.2 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
| 2.2 | 2.2 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 2.2 | 11.2 | GO:0030070 | insulin processing(GO:0030070) |
| 2.2 | 6.6 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 2.2 | 33.1 | GO:0015671 | oxygen transport(GO:0015671) |
| 2.2 | 13.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 2.2 | 8.7 | GO:0003335 | corneocyte development(GO:0003335) |
| 2.2 | 6.5 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 2.2 | 30.4 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
| 2.2 | 12.9 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 2.1 | 6.4 | GO:0044771 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 2.1 | 15.0 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 2.1 | 12.9 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 2.1 | 36.4 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
| 2.1 | 4.2 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 2.1 | 6.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 2.1 | 8.4 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 2.1 | 23.1 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 2.1 | 14.6 | GO:0009597 | detection of virus(GO:0009597) |
| 2.1 | 6.2 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
| 2.1 | 6.2 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 2.1 | 6.2 | GO:0009726 | detection of endogenous stimulus(GO:0009726) |
| 2.1 | 6.2 | GO:0097352 | autophagosome maturation(GO:0097352) |
| 2.0 | 4.1 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 2.0 | 8.1 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 2.0 | 20.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 2.0 | 12.1 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 2.0 | 2.0 | GO:0072254 | metanephric mesangial cell differentiation(GO:0072209) metanephric glomerular mesangial cell differentiation(GO:0072254) |
| 2.0 | 10.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 2.0 | 8.0 | GO:0015811 | L-cystine transport(GO:0015811) |
| 2.0 | 6.0 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
| 2.0 | 12.1 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 2.0 | 10.0 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 2.0 | 5.9 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 2.0 | 5.9 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 1.9 | 15.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 1.9 | 5.8 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
| 1.9 | 7.7 | GO:0019740 | regulation of nitrogen utilization(GO:0006808) nitrogen utilization(GO:0019740) negative regulation of cellular pH reduction(GO:0032848) CD8-positive, alpha-beta T cell lineage commitment(GO:0043375) negative regulation of retinal cell programmed cell death(GO:0046671) |
| 1.9 | 11.5 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 1.9 | 26.4 | GO:0035878 | nail development(GO:0035878) |
| 1.9 | 3.8 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 1.9 | 7.5 | GO:0060023 | soft palate development(GO:0060023) |
| 1.8 | 5.5 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 1.8 | 9.2 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
| 1.8 | 14.7 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 1.8 | 5.5 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
| 1.8 | 3.6 | GO:0070781 | response to biotin(GO:0070781) |
| 1.8 | 3.6 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 1.8 | 8.9 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
| 1.8 | 7.1 | GO:0010814 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 1.8 | 1.8 | GO:0030104 | water homeostasis(GO:0030104) multicellular organismal water homeostasis(GO:0050891) |
| 1.8 | 14.2 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
| 1.8 | 7.1 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 1.8 | 7.1 | GO:1903960 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) |
| 1.8 | 7.1 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 1.8 | 10.6 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
| 1.8 | 7.1 | GO:0072104 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 1.8 | 5.3 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 1.7 | 24.4 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 1.7 | 10.4 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 1.7 | 10.4 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
| 1.7 | 5.1 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
| 1.7 | 5.1 | GO:1904530 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 1.7 | 13.7 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 1.7 | 8.5 | GO:0060214 | endocardium morphogenesis(GO:0003160) endocardium formation(GO:0060214) |
| 1.7 | 1.7 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 1.7 | 5.0 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 1.6 | 62.4 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
| 1.6 | 4.9 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 1.6 | 9.8 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 1.6 | 3.3 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 1.6 | 4.9 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
| 1.6 | 14.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 1.6 | 12.9 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 1.6 | 9.6 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
| 1.6 | 12.8 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
| 1.6 | 3.2 | GO:0018282 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 1.6 | 3.2 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
| 1.6 | 4.7 | GO:0002818 | intracellular defense response(GO:0002818) |
| 1.6 | 6.3 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
| 1.6 | 11.0 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) |
| 1.6 | 4.7 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 1.6 | 43.7 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) |
| 1.6 | 4.7 | GO:0046061 | dATP catabolic process(GO:0046061) |
| 1.6 | 26.4 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 1.6 | 3.1 | GO:0060061 | Spemann organizer formation(GO:0060061) |
| 1.5 | 6.2 | GO:0032053 | ciliary basal body organization(GO:0032053) |
| 1.5 | 1.5 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
| 1.5 | 7.7 | GO:1902075 | cellular response to salt(GO:1902075) |
| 1.5 | 7.6 | GO:0046898 | response to cycloheximide(GO:0046898) |
| 1.5 | 3.0 | GO:0097581 | lamellipodium organization(GO:0097581) |
| 1.5 | 12.2 | GO:0015705 | iodide transport(GO:0015705) |
| 1.5 | 7.6 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 1.5 | 7.5 | GO:1903412 | response to bile acid(GO:1903412) |
| 1.5 | 5.9 | GO:0070384 | Harderian gland development(GO:0070384) |
| 1.5 | 8.9 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 1.5 | 10.4 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 1.5 | 4.4 | GO:0033025 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 1.5 | 10.4 | GO:0006489 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 1.5 | 220.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 1.5 | 14.7 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 1.5 | 8.7 | GO:0030916 | otic vesicle formation(GO:0030916) |
| 1.4 | 15.8 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 1.4 | 7.2 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 1.4 | 9.9 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 1.4 | 4.2 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 1.4 | 4.2 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 1.4 | 5.6 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 1.4 | 4.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 1.4 | 16.7 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 1.4 | 20.6 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 1.4 | 9.6 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
| 1.4 | 2.7 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 1.4 | 6.8 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 1.4 | 5.4 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 1.4 | 4.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 1.4 | 9.5 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
| 1.4 | 2.7 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
| 1.4 | 5.4 | GO:0070253 | somatostatin secretion(GO:0070253) |
| 1.3 | 2.7 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 1.3 | 5.3 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 1.3 | 4.0 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 1.3 | 6.6 | GO:0016926 | protein desumoylation(GO:0016926) |
| 1.3 | 6.6 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
| 1.3 | 3.9 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 1.3 | 6.5 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 1.3 | 16.8 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 1.3 | 3.9 | GO:0051697 | protein delipidation(GO:0051697) |
| 1.3 | 18.1 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
| 1.3 | 9.0 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 1.3 | 3.8 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 1.3 | 25.5 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 1.3 | 8.9 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 1.3 | 6.3 | GO:0099551 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 1.3 | 3.8 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 1.2 | 12.5 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
| 1.2 | 6.2 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 1.2 | 2.5 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 1.2 | 3.7 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 1.2 | 2.5 | GO:2000366 | regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
| 1.2 | 6.2 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) |
| 1.2 | 3.7 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
| 1.2 | 12.3 | GO:0019627 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
| 1.2 | 3.7 | GO:1904899 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 1.2 | 22.0 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 1.2 | 3.7 | GO:2000537 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 1.2 | 7.3 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
| 1.2 | 7.3 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 1.2 | 4.8 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
| 1.2 | 7.1 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 1.2 | 7.1 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 1.2 | 3.5 | GO:0090298 | negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
| 1.2 | 5.9 | GO:2000639 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 1.2 | 4.7 | GO:0021633 | optic nerve structural organization(GO:0021633) |
| 1.2 | 7.0 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 1.2 | 4.7 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 1.1 | 3.4 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 1.1 | 1.1 | GO:1901863 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
| 1.1 | 4.4 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
| 1.1 | 6.6 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
| 1.1 | 14.3 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 1.1 | 14.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 1.1 | 3.2 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
| 1.1 | 15.1 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 1.1 | 3.2 | GO:0097178 | ruffle assembly(GO:0097178) |
| 1.1 | 5.3 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
| 1.1 | 6.4 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 1.1 | 2.1 | GO:0031670 | cellular response to nutrient(GO:0031670) |
| 1.1 | 19.1 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
| 1.1 | 13.7 | GO:0031268 | pseudopodium organization(GO:0031268) |
| 1.1 | 22.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 1.0 | 3.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 1.0 | 3.1 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 1.0 | 3.1 | GO:1903797 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) positive regulation of inorganic anion transmembrane transport(GO:1903797) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 1.0 | 26.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 1.0 | 13.4 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 1.0 | 4.1 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 1.0 | 48.0 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 1.0 | 4.1 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 1.0 | 5.1 | GO:0060174 | limb bud formation(GO:0060174) |
| 1.0 | 6.1 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 1.0 | 10.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 1.0 | 2.0 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
| 1.0 | 4.0 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 1.0 | 3.0 | GO:0021718 | pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 1.0 | 4.0 | GO:0035900 | response to isolation stress(GO:0035900) |
| 1.0 | 8.9 | GO:1903276 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
| 1.0 | 2.9 | GO:0032094 | response to food(GO:0032094) |
| 1.0 | 9.8 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 1.0 | 23.2 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
| 1.0 | 3.9 | GO:0031346 | positive regulation of cell projection organization(GO:0031346) |
| 1.0 | 2.9 | GO:0070105 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 1.0 | 7.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 1.0 | 2.9 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 1.0 | 8.6 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 1.0 | 1.9 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 1.0 | 23.8 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 1.0 | 1.0 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 0.9 | 0.9 | GO:0030432 | peristalsis(GO:0030432) |
| 0.9 | 0.9 | GO:0035150 | regulation of tube size(GO:0035150) regulation of blood vessel size(GO:0050880) |
| 0.9 | 2.8 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
| 0.9 | 12.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.9 | 9.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.9 | 0.9 | GO:0035962 | response to interleukin-13(GO:0035962) |
| 0.9 | 8.4 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.9 | 3.7 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 0.9 | 3.7 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
| 0.9 | 14.8 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.9 | 11.1 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.9 | 5.5 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.9 | 2.7 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.9 | 5.5 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.9 | 2.7 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
| 0.9 | 1.8 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
| 0.9 | 6.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.9 | 3.6 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.9 | 26.1 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.9 | 10.8 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.9 | 9.0 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
| 0.9 | 2.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.9 | 2.7 | GO:0071934 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
| 0.9 | 17.7 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
| 0.9 | 2.6 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.9 | 4.3 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.9 | 4.3 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
| 0.9 | 1.7 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 0.9 | 3.4 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.9 | 76.7 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.8 | 3.4 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
| 0.8 | 4.2 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
| 0.8 | 18.6 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.8 | 12.6 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.8 | 6.7 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.8 | 5.0 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.8 | 5.8 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.8 | 2.5 | GO:2000683 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) regulation of cellular response to X-ray(GO:2000683) positive regulation of cellular response to X-ray(GO:2000685) |
| 0.8 | 5.0 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.8 | 4.1 | GO:0000187 | activation of MAPK activity(GO:0000187) |
| 0.8 | 5.8 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.8 | 5.0 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
| 0.8 | 3.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.8 | 2.5 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.8 | 34.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.8 | 3.3 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
| 0.8 | 25.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.8 | 13.9 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.8 | 5.7 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
| 0.8 | 1.6 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.8 | 2.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
| 0.8 | 3.2 | GO:0006551 | leucine metabolic process(GO:0006551) |
| 0.8 | 9.7 | GO:0036065 | fucosylation(GO:0036065) |
| 0.8 | 21.7 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
| 0.8 | 4.0 | GO:0060481 |